Marco Marchetti

PellePharm, Inc. engages in the operation of a biotechnology company committed to targeting rare dermatologic diseases. It develops Patidegib , an investigational topical treatment designed to mitigate the tumor burden in patients with Gorlin Syndrome and Basal Cell Carcinomas (BCCs), and other potential indications. The firm also focuses on commercializing Patidegib treatment by potentially reducing invasive and painful surgeries. The company was founded by Michael Henderson, Jean Tang, Ervin Epstein, and Philip Beachy and is headquartered in San Francisco, CA.

Picchio Pharma, Inc. engages in acquiring, developing, and commercializing new therapeutic products and technologies. The company was founded in 2001 and is headquartered in Laval, Canada.

TV2 Danmark A/S is Denmark's commercial television which provides television-broadcasting services. The company telecasts serials, news, films, sports and youth oriented programs. It has branches in Norway and Sweden. The company was founded in 1988 and is located in Odense, Denmark.

LEO Pharma A/S develops, manufactures and markets drugs within the area of dermatology and critical care medicine. It supplies medicines to patients suffering from skin infections and diseases such as psoriasis and eczema, thrombosis, kidney disease and cancer. The company was founded by August Kongsted and Anton Antons in 1908 and is headquartered in Ballerup, Denmark.

CellCarta Biosciences, Inc. develops proteomics and immune monitoring services. The firm offers integrated platforms in proteomics and immune monitoring services to the pharmaceutical and biotechnology industry. Its services include biomarker discovery, cell engine software, cellular enumeration, clinical laboratory services, functional profiling, host cell proteins detection, phenotyping characterization and receptor occupancy. The company was founded by Martin LeBlanc in 2000 and is headquartered in Montréal, Canada.

BIOTECanada serves as a national association for Canada's health, industrial and agricultural biotechnology sectors. The company was founded in 1986 and is headquartered in Ottawa, Canada.

Prognomix, Inc. develops market molecular diagnostic kits for testing of diabetes complications. Its products include PGX IR01, PGx GR01, PGx CD01 and PGx IR02. The firm focuses on discovery and clinical application of genomic signatures predictive of susceptibility to diseases, their complications and individual therapeutic responsiveness. The company was founded by Johanne Tremblay and Pavel Hamet in 2005 and is headquartered in Montreal, Canada.

Fédération des Sociétés Alzheimer du Québec is a private company based in Montréal, Canada.

G3 Good Governance Group Ltd. provides business intelligence, risk advisory, litigation support and information security consultancy services. It offers commercial strategy, decision making and risk mitigation consultancy, compliance, dispute resolution, cyber security and corporate social responsibility advisory services. The firm serves law firms, corporations, investment banks and family offices worldwide. The company was founded in 2004 and is headquartered in London, the United Kingdom.

Part of LEO Fondet, LEO Laboratories Ltd. is a British dermatology company that aims to improve the lives of people living with a dermatological condition. The company is based in Hurley, UK. LEO Laboratories supplies treatments to people with medical needs in more than 130 countries around the world and strives to positively impact the lives of 125 million people through medical dermatology by 2025. Founded in 1960 and headquartered in Denmark, the company currently employs 6,000 professionals across 60 countries.

Kinnevik New Ventures AB. (KNV) is a venture capital subsidiary of Kinnevik AB founded in 1936. The firm is headquartered in Stockholm, Sweden.

eSight Corp. manufactures and sells electronic eyewear. The firm offers binocular, OLED color display that fits over prescription lenses, accelerometers, gyroscope, IR range finder and temperature sensor. The company was founded by Conrad W. Lewis in 2006 and is headquartered in Toronto, Canada.

Part of Kinnevik AB, Recovia AB is a Swedish company that specializes in renewable and sustainable energy. Recovia is based in Stockholm, Sweden. Recovia owns and operates installations that have abated greenhouse gas emissions corresponding to several hundreds of thousands of tons of CO2. The company develops projects in landfill gas to power and sells renewable power. Recovia is also developing gasification projects and renewable hydrogen based on new technologies. The company's philosophy is to recover as much economic value and energy as possible from waste streams. The company was founded in 2010 by Warren Campbell and Fredrik Carlman, who has been the CEO since then.

Venus Concept Ltd. provides procedural medical devices for aesthetic procedures. The firm specializes in advanced non-surgical platforms for body contouring, skin tightening, cellulite and scar reduction, skin resurfacing, skin rejuvenation, acne reduction, and hair removal. The company was founded by Domenic Serafino, Oded Ron-Edoute, and Orit Fishgold Ron-Edoute and is headquartered in Toronto, Canada.

HydRx Farms Ltd. operates as a biopharmaceutical licensed dealer with a focus on developing and commercializing pharmaceutical-grade cannabinoid derivative products. The firm engages in the producing and processing of medical marihuana and other controlled substances under the Health Canada Medical Marihuana Purpose Regulation (MMPR) program and other NCR regulations. The company was founded by Thomas Jefferd and Trevor Folk in 2014 and is headquartered in Whitby, Canada.

Venus Concept USA, Inc. provides non-surgical aesthetic equipment to physicians and clinics for body contouring, skin tightening, and cellulite reduction. The company is headquartered in Weston, FL.

Scientus Pharma, Inc. provides biopharmaceutical products extracted from the cannabis plant. The private company is based in Whitby, Canada.

ResoTher Pharma is a privately held clinical-stage biotech company based in Copenhagen, Denmark. ResoTher Pharma focuses on developing compounds that induce inflammatory resolution in cardiovascular diseases. The Danish company's lead compound, RTP-026, has shown to have a profound effect on reducing infarction size and restoring cardiac function to a pre-infarction level. ResoTher Pharma's mission is to create novel medicines that benefit patients in need by addressing unmet needs in CVD inflammation through endogenous immune regulatory pathways. The company was founded in 2016 by Thomas Jonassen and is privately owned by a group of prominent Danish investors.

Venus Concept Canada Corp. provides medical and aesthetic technology equipment. The company is headquartered in Toronto, Canada.

Part of Sigmacon Holding SA, Sigmacon (UK) Ltd. is a market leader in innovative technology and high-class laser devices for surgery and ophthalmology. The company is based in Middlesex, UK. Sigmacon supplies a range of ophthalmic products, from SLT lasers to ophthalmic furniture, from brands such as Lumenis and Rini. Founded in 1978, the British company offers an impressive range of products from the world's leading manufacturers, with a focus on providing their customers with the best solutions to meet their clinical requirements.